Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
151 |
|
| Actual shortage: | 6 (4%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (92%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-01-25 | 2019-03-13 | 73545 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-05-07 | 2020-09-08 | 83368 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2021-06-04 | 2022-01-04 | 140457 |
| TRIESENCE | 40MG | SUSPENSION | Actual shortage | 2022-03-30 | 2024-03-21 | 157590 |
| TEGRETOL CR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-05-07 | 2024-05-13 | 227209 |
| TOBREX | 3MG | OINTMENT | Resolved | 2018-01-08 | 2018-01-30 | 35259 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-01-08 | 2019-01-28 | 71609 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-02-11 | 2019-03-09 | 75340 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-03-11 | 2019-04-06 | 78252 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-04-08 | 2019-04-26 | 80771 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-06-21 | 2019-09-06 | 87200 |
| LUTATHERA | 370MBq | SOLUTION | Resolved | 2022-05-06 | 2022-06-14 | 160113 |
| DIOVAN | 320MG | TABLET | Resolved | 2020-04-22 | 2020-05-05 | 112809 |
| TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2019-02-25 | 2019-03-07 | 76783 |
| TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2020-11-09 | 2020-12-04 | 128180 |
| TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2022-11-22 | 2023-04-13 | 175426 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Resolved | 2021-10-28 | 2022-01-17 | 148460 |
| ZOFRAN | 2MG | SOLUTION | Resolved | 2018-02-22 | 2018-04-09 | 40627 |
| RITALIN-SR TAB 20MG | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-25 | 2017-06-02 | 11280 |
| RITALIN 20MG | 20MG | TABLET | Resolved | 2017-06-07 | 2017-08-31 | 12261 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-26 | 2020-11-26 | 128967 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |
| ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |